Evidence map›Paper›PMID 35287605›Full record

ArticleBMC infectious diseases2022

On the accuracy of short-term COVID-19 fatality forecasts.

Nino Antulov-Fantulin, Lucas Böttcher

Abstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nino Antulov-FantulinComputational Social Science, ETH Zurich, 8092, Zurich, Switzerland. anino@ethz.ch.ORCID http://orcid.org/0000-0002-4337-2475
Lucas BöttcherComputational Social Science, Frankfurt School of Finance and Management, 60322, Frankfurt, Germany.

Funding

horizon 2020 framework programme 871042swiss national fund P2EZP2_191888
6 · The paper itself

Abstract

backgroundForecasting new cases, hospitalizations, and disease-induced deaths is an important part of infectious disease surveillance and helps guide health officials in implementing effective countermeasures. For disease surveillance in the US, the Centers for Disease Control and Prevention (CDC) combine more than 65 individual forecasts of these numbers in an ensemble forecast at national and state levels. A similar initiative has been launched by the European CDC (ECDC) in the second half of 2021.

methodsWe collected data on CDC and ECDC ensemble forecasts of COVID-19 fatalities, and we compare them with easily interpretable "Euler" forecasts serving as a model-free benchmark that is only based on the local rate of change of the incidence curve. The term "Euler method" is motivated by the eponymous numerical integration scheme that calculates the value of a function at a future time step based on the current rate of change.

resultsOur results show that simple and easily interpretable "Euler" forecasts can compete favorably with both CDC and ECDC ensemble forecasts on short-term forecasting horizons of 1 week. However, ensemble forecasts better perform on longer forecasting horizons.

conclusionsUsing the current rate of change in incidences as estimates of future incidence changes is useful for epidemic forecasting on short time horizons. An advantage of the proposed method over other forecasting approaches is that it can be implemented with a very limited amount of work and without relying on additional data (e.g., data on human mobility and contact patterns) and high-performance computing systems.

Indexed as

COVID-19EpidemicsInfluenza, HumanForecastingHumansSeasonsComputer-assistedCOVID-19Epidemiological monitoringForecastingNumerical analysis

Identifiers

PMID35287605
PMCPMC8919163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.